Generate a tailored SOP for Dr. Andreas Stahl. Improve your application with a focused, well-structured draft.
Andreas Stahl is the Ruth Okey Chair Professor in Metabolic Biology at UC Berkeley, focusing on advancing human health through engineering solutions for obesity-related disorders such as Type-2 Diabetes Mellitus (T2DM) and Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD). His research investigates the molecular mechanisms governing lipid uptake, particularly fatty acids and mitochondrial function, and explores the role of biomechanical forces in brown adipose tissue (BAT) activation through novel lipid nanoparticle-based approaches. Stahl's laboratory is also committed to developing New Approach Methodologies (NAM) based on human induced pluripotent stem cell-derived microphysiological systems (organ-on-a-chip devices) for functional interrogation of the fat-liver axis, assessing biological mechanisms of aging, diseases, and testing pharmacological interventions in human-relevant preclinical models. He is a member of QB3-Berkeley, the UC Berkeley-UCSF Graduate Program in Bioengineering, and serves as Chair of the Metabolic Biology Graduate Program, teaching and mentoring students in metabolic biology and its connections to human diseases.
The Mathematics Subject GRE is required for the Fall 2026 admissions cycle. General GRE is optional.